Eris Lifesciences reported 16.2% rise in consolidated net profit to Rs 107.7 crore on 16% increase in net sales to Rs 325.27 crore in Q2 FY21 over Q2 FY20.
Profit before tax (PBT) in Q2 September 2020 stood at Rs 115.84 crore, up by 12.7% from Rs 102.77 crore in Q2 September 2019. Tax expense during the quarter declined 19.4% year-on-year (YoY) to Rs 81 crore.
EBITDA rose 13.6% to Rs 124.80 crore in Q2 FY21 from Rs 109.80 crore in Q2 FY20. EBITDA margin stood at 37.8% as on 30 September 2020 as against 38.6% as on 30 September 2019.
Eris Lifesciences is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian pharmaceutical market.
The scrip fell 2.65% to Rs 504.45 on the BSE. It traded in the range of 502.50 and 517.50 so far during the day.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app